HOME >> BIOLOGY >> NEWS
'Homegrown' relief for victims of arsenic poisoning in South Asia

The World Health Organization calls it the "largest mass poisoning of a population in history."

Halfway around the globe, in a region that is no stranger to misery, 100 million people in eastern India and Bangladesh suffer from skin ulcers, tumors and other debilitating and even fatal consequences of arsenic poisoning.

The crisis, says Arup SenGupta, who grew up in the Indian state of West Bengal, is "the biggest natural calamity of our time." Like many environmental problems in developing countries, he says, it cries out for a homegrown solution.

SenGupta, professor of civil and environmental engineering at Lehigh University, says he has developed such a solution in the form of an inexpensive, simple well-head unit that removes arsenic from water wells.

Since 1997, his system has been installed in more than 100 village drinking wells near the cities of Howrah and Calcutta in West Bengal.

Arsenic levels in the filtered wells have plummeted from toxic rates of 100 to 500 parts per billion, SenGupta says, to well below the 50-ppb maximum permitted by the Indian government. Arsenicosis sufferers have found relief from their symptoms, and reports of new cases have plummeted.

SenGupta will visit West Bengal for a week beginning Dec. 22, and will tour several villages where his system has been installed.

Each of SenGupta's systems is built in India and installed by students and professors from Bengal Engineering College in Howrah for a cost of $1,200 to $1,500. The units last about 15 years, although the arsenic-removing materials must be regenerated once or twice a year, and the arsenic requires safe disposal.

Funds for the projected have been provided by Water For People and other non-profit groups and private foundations.

The systems, which are operated with a hand pump and need no electric power or chemicals, are maintained by villagers with help from Bengal Engineering College. Villagers are also
'"/>

Contact: Kurt Pfitzer
kap4@lehigh.edu
610-758-3017
Lehigh University
8-Dec-2003


Page: 1 2 3

Related biology news :

1. Flexible pain relief with morphine-free poppy
2. Cannabinoids spell relief in colon inflammation
3. Puffer fish biotoxin provides promising relief in cancer pain
4. Naked mole-rats bare pain relief clues
5. New therapies under development promise improved relief for Non-Hodgkins Lymphoma cancer patients
6. ENBREL provided rapid and significant relief for psoriasis patients in second pivotal study
7. ENBREL combo therapy inhibits joint damage progression, offers significant RA symptom relief
8. Birth control pill may provide relief for PMS
9. Pain-relief drug may prevent lung problems, blindness in premature infants
10. Patch delivers longer, deeper relief from dental pain
11. Researchers find gene involved in pain relief

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Homegrown relief for victims arsenic poisoning South Asia

(Date:6/16/2015)... , June 16, 2015 /CNW Telbec/ - handyem ... centralized around the incorporation of handyem,s HPC-150 portable ... laboratory, the Mo-POD™. This unprecedented model of mobile ... Conference at the Pennsylvania ... June 15 th to 18 th ...
(Date:6/16/2015)... , June 16, 2015 Fingerprint Cards ... fingerprint sensors in the company,s portfolio from one of its ... planned to mainly take place during the third quarter 2015. ... Asia . Jörgen Lantto, CEO of ...   the   growing interest from smartphone OEMs in integrating ...
(Date:6/15/2015)... June 16, 2015 According to ... by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, ... 2020" published by MarketsandMarkets, The Natural Language Processing Market ... CAGR of 18.4% for the forecast period 2015-2020. ... 46 F igures spread   through 155 P ...
Breaking Biology News(10 mins):handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2Natural Language Processing Market Worth $13.4 Billion by 2020 2Natural Language Processing Market Worth $13.4 Billion by 2020 3Natural Language Processing Market Worth $13.4 Billion by 2020 4Natural Language Processing Market Worth $13.4 Billion by 2020 5
(Date:7/2/2015)... ... July 02, 2015 , ... In’Tech ... surgical instruments in Orthopedics, announced today the acquisition of Turner Medical, Inc ... provider of surgical instruments to the Spine Industry. The acquisition of Turner Medical ...
(Date:7/1/2015)... , July 1, 2015   Decision ... frequently cited advantages of Otezla are its oral ... profile, as reported by surveyed rheumatologists. Otezla was ... for the treatment of active psoriatic arthritis in ... current standard of care includes conventional oral treatments ...
(Date:7/1/2015)... ALTO, Calif. , July 1, 2015 /PRNewswire/ ... focused on the development of groundbreaking drugs to ... (ALS), announced today that Robert G. Miller ... Center at Sutter Health,s California Pacific Medical Center ... The ALS Association for $1.5 million to help ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business plan ... lower the barriers to innovation in life sciences R&D. The Pistoia Alliance President’s Startup ... prizes of US$15,000 and a period of expert mentorship from a senior industry figure ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
Cached News: